The Valley Desk

NCT06617923 · Interventional trial

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Overall registry status Active not recruiting

Phase 2

Conditions Fallopian Tube Cancer, Ovary Cancer, Primary Peritoneal Cavity Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov